Finland’s lack of cancer data and funding cuts lengthen treatment delays, harming survival

Finland’s health system lacks a national cancer quality registry, and the government has eliminated budget support for creating one, leaving researchers to analyse delays in isolated cancer types. A lung-cancer study coordinated by Professor Outi Kuittinen found the average interval from first symptoms to treatment to be roughly 155 days, with over 50 days attributable to patient factors, 41 days to primary care and 58 days to specialised care.

By contrast, Sweden records a total delay of 107 days and Denmark 67 days. The report also highlights individual cases, such as a 39-year-old woman whose breast-cancer tumour grew dramatically while waiting six weeks for treatment, and a young woman whose cancer was missed due to a biopsy error. Finland’s 2025 national cancer strategy calls for 140 million euros, but the upcoming budget provides no new funding and even cuts 400,000 euros earmarked for the registry. Officials argue that competing health priorities dictate spending, while oncologists warn that the lack of investment threatens both lives and long-term costs.